Progressieve Supranucleaire Verlamming. Interventie middels acetylcholineesteraseremmer?

@article{Nijboer2009ProgressieveSV,
  title={Progressieve Supranucleaire Verlamming. Interventie middels acetylcholineesteraseremmer?},
  author={H. Nijboer and P. Dautzenberg},
  journal={Tijdschrift voor Gerontologie en Geriatrie},
  year={2009},
  volume={40},
  pages={133-137}
}
SamenvattingProgressive supranucleair verlamming (PSP) is een zeldzame, ernstige progressieve neurologische aandoening met complexe symptomatologie. Wij beschrijven een 3-tal casussen, die in de periode 2005-2008 zijn vervolgd. Ondanks de aanwezigheid van internationale criteria sinds 1996, zijn de diagnosestelling en behandeling nog steeds moeilijk. In deze 3 casussen is gekozen voor rivastigmine; redenen daarvoor worden kort toegelicht. Onder het gebruik van rivastigmine zijn cognitieve… Expand

References

SHOWING 1-10 OF 21 REFERENCES
Progressive Supranuclear Palsy: A Current Review
TLDR
It is clear that Progressive supranuclear palsy continues to be an under-recognized disorder with multilevel involvement of the neuraxis that helps differentiate it from other akinetic rigid syndromes such as PD. Expand
Zolpidem in progressive supranuclear palsy.
To the Editor: Progressive supranuclear palsy is an atypical Parkinsonian syndrome characterized by motor symptoms (voluntary-eye-movement abnormalities, akinesia, rigidity, postural instability,Expand
Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome)
TLDR
Criteria that support the diagnosis of progressive supranuclear palsy, and that exclude diseases often confused with PSP, are presented. Expand
Donepezil in the treatment of progressive supranuclear palsy
TLDR
Cholinergic replacement therapy alone is not likely to improve symptoms in a disorder characterized by a more widespread impairment of monoaminergic systems, and the lack of effect of donepezil in this disorder is confirmed. Expand
Characteristics and symptom management of progressive supranuclear palsy: a multidisciplinary approach.
  • C. Ward
  • Medicine
  • The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses
  • 2006
TLDR
The neuroscience nurse who is knowledgeable about PSP and the complex way in which it overlaps with numerous other devastating neurological diagnoses can help in achieving the correct diagnosis and treatment. Expand
PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.
TLDR
A progressive brain disease featured by supranuclear ophthalmoplegia affecting chiefly vertical gaze, pseudobulbar palsy, dysarthria, dystonic rigidity of the neck and upper trunk, and other less constant cerebellar and pyramidal symptoms. Expand
Cholinergic neuronal loss in the basal forebrain and mesopontine tegmentum of progressive supranuclear palsy and corticobasal degeneration
TLDR
In PSP, cholinergic neurons in the LdtgN are likely to be more vulnerable than PptgN and NBM, while in CBD, the number of neurons and the ChAT-positivity rate of remaining neurons were decreased more in CBD than PSP. Expand
Retrospective study of drug response in 87 patients with progressive supranuclear palsy.
TLDR
Monotherapy tended to show more benefit and fewer adverse effects than polypharmacy, and levodopa/carbidopa, amantadine, selegiline, and amitriptyline gave the best risk/benefit ratios. Expand
Creutzfeldt-Jakob disease with slow progression. A mimickry of progressive supranuclear palsy.
TLDR
A 67-year old female patient with initial falls and vertical gaze palsy is presented, suggesting the diagnosis of Progressive Supranuclear Palsy (PSP), which adds to the scare literature of slowly evolving CJD mimicking Parkinsonism related to tauopathies. Expand
Rivastigmine in subcortical vascular dementia: A randomized, controlled, open 12-month study in 208 patients
TLDR
Improvements in domains that characterize subcortical VaD were observed, indicating that rivastigmine may have provided targeted treatment in areas of the brain that are particularly affected in this patient population. Expand
...
1
2
3
...